Systech Introduces Solution for Managing Pharma Supply Chain Exceptions
The offering reportedly helps avoid product quarantine.
Systech, a Markem-Imaje solutions brand that offers brand protection via packaging serialization, has released a rework offering for managing exceptions in the pharma supply chain.1
The solution is expected to help with exception management capabilities, starting from the product line all the way through the supply chain in order to assist contract manufacturing organizations, chief procurement officers, manufacturers, and distributors with associated risks, by limiting data misalignment, and product delays. After all, being able to avoid product quarantines and other supply chain delays is essential.
However, as trading partners work to implement and adjust their processes to adhere to the latest Drug Supply Chain Security Act (DSCSA) guidelines, a learning curve is expected. According to Systech, the volume of errors attributed to inconsistencies between the data received and the product received in the shipment are expected to increase by 5-10 times.
The company’s product provides rapid deployment services, a built-in data inspector that can adjust to any workflow, and the ability to connect to any Level 4 platform.
Highlights of Systech’s exception handling and rework solution include:
- A path to compliance with an EPCIS checker that functions as a built-in data inspector, decreasing the number of hours needed to check and merge the data
- Multi-scan and mobile flexibility that allows for efficiency, in order to further enhance time to production
- A communication hub that is able to automate notifications to trading partners and regulatory authorities, which can help avoid aforementioned supply chain delays
“Our new feature-rich, exception handling solution addresses a diverse set of use cases, leveraging our vast experience in providing rework up and down the stack and ensuring seamless trading partner connectivity,” said Sreedhar Patnala, Systech’s VP of digital products. “Systech’s highly reliable and scalable solutions effectively mitigate risk and keep the data and product moving.”
For more additional coverage, Systech’s Dave DeJean, the company’s VP of global strategic accounts, recently joined The PC Podcast,2 offering up an outlook on where the pharma supply chain stands in terms of adhering to the DSCSA.
Reference
1. Systech launches innovative exception handling and rework solution. Systech. News release. February 27, 2024. Accessed March 1, 2024. https://www.systechone.com/systech-launches-innovative-exception-handling-and-rework-solution/
2. Saraceno N. Complying With the DSCSA. Pharmaceutical Commerce. Podcast episode. January 24, 2024. Accessed March 1, 2024. https://www.pharmaceuticalcommerce.com/view/complying-with-the-dscsa
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
